Support the Fight for Access | TheraPsil

Approved for MAiD.
Denied psilocybin therapy.

In Canada, patients are approved to die before they're approved to heal. TheraPsil is fighting to change that.

Pete's story

Pete asked for relief. He was denied.

Pete Pearson is living with idiopathic pulmonary fibrosis, a terminal lung disease with no cure. With support from his doctors, he applied to Health Canada for legal access to psilocybin therapy to ease his end-of-life anxiety and distress.

He waited nearly a year. His request was denied.

Weeks later, he was approved for Medical Assistance in Dying.

Health Canada told Pete he's too sick to live — but not sick enough to try psilocybin.
Support patients like Pete

"I don't want to die. I want to live whatever time I have left with peace, with dignity, and without this constant panic hanging over me."

Pete Pearson
Jody's story

A judge had to order Health Canada to reconsider.

Jody Lance is a Calgary man who spent years living with cluster headaches, one of the most painful conditions known to medicine. Conventional treatments failed. Small doses of psilocybin were the only thing that worked.

Health Canada denied his application. It took a Federal Court judge ordering a new decision before Health Canada would reconsider. Jody was also approved for MAiD during this time.

When his renewal came up, Health Canada sat on the file for months. Another court application was needed just to get a response. That is what patients are up against.

Patients should not need a lawyer and a Federal Court judge just to access their medicine.
Help fund the legal fight
The reality

The evidence is clear. The access is not.

Psilocybin therapy has demonstrated meaningful results in clinical research, yet patients continue to face bureaucratic denial while Canada's MAiD program expands.

80%

of participants experience significant relief from depression and anxiety after psilocybin therapy in clinical trials.

5.1%

of all deaths in Canada are now MAiD — while psilocybin therapy, with strong evidence behind it, remains inaccessible.

0

guaranteed access pathways exist for eligible patients seeking psilocybin therapy in Canada today.

Where your donation goes

Your support funds the fight for access.

Every dollar goes directly toward the legal strategy, public education, and patient support needed to challenge Health Canada's barriers to psilocybin therapy in Canada.

Legal and regulatory advocacy

Challenge Health Canada's denials in court, push for regulatory reform, and defend the right to compassionate care.

Direct patient support

Help patients and families navigate delays, denials, media attention, and next steps when the system fails them.

Public education and storytelling

Bring stories like Pete's and Jody's into public view so this contradiction cannot be ignored or buried.

Healthcare professional access

Support trained clinicians fighting for the right to offer evidence-based psilocybin care to the patients who need it.